Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity

Lipid Transmitter Signaling as a New Target for Treatment of Cocaine Addiction: New Roles for Acylethanolamides and Lysophosphatidic Acid

(2013) Laura Orio et al.   CURRENT PHARMACEUTICAL DESIGN

Deficits in Ventromedial Prefrontal Cortex Group 1 Metabotropic Glutamate Receptor Function Mediate Resistance to Extinction during Protracted Withdrawal from an Extensive History of Cocaine Self-Administration

(2013) O. Ben-Shahar et al.   JOURNAL OF NEUROSCIENCE

Dorsolateral caudate nucleus differentiates cocaine from natural reward-associated contextual cues

(2013) H.-S. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPARα receptor-independent mechanism

(2012) Ainhoa Bilbao et al.   ADDICTION BIOLOGY

Effect of an Acute Consumption of a Moderate Amount of Ethanol on Plasma Endocannabinoid Levels in Humans

(2012) Matthias Feuerecker et al.   ALCOHOL AND ALCOHOLISM

Regulation of GPR119 receptor activity with endocannabinoid-like lipids

(2012) Samreen K. Syed et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Diagnosis and Consequences of Cocaine Addiction

(2012) L. Karila et al.   CURRENT MEDICINAL CHEMISTRY

Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats

(2012) Patricia Rivera et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Cocaine self-administration differentially modulates the expression of endogenous cannabinoid system-related proteins in the hippocampus of Lewis vs. Fischer 344 rats

(2012) Patricia Rivera et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Endocannabinoids Measurement in Human Saliva as Potential Biomarker of Obesity

(2012) Isabelle Matias et al.   PLoS One

Psychiatric comorbidity in cocaine users treated in therapeutic community: Substance-induced versus independent disorders

(2012) Esperanza Vergara-Moragues et al.   PSYCHIATRY RESEARCH

Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia

(2012) Joëlle Desfossés et al.   Frontiers in Psychiatry

Role of the Endocannabinoid System in Alcoholic Liver Disease

(2011) S.V. Siegmund   DIGESTIVE DISEASES

Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients

(2011) Deborah S. Hasin et al.   DRUG AND ALCOHOL DEPENDENCE

Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity

(2011) A. Quercioli et al.   EUROPEAN HEART JOURNAL

Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?

(2011) C. Schüle et al.   NEUROSCIENCE

Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors

(2011) Antonia Serrano et al.   PHARMACOLOGY & THERAPEUTICS

Enzymological studies on the biosynthesis of N-acylethanolamines

(2010) Natsuo Ueda et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Blockade of Nicotine Reward and Reinstatement by Activation of Alpha-Type Peroxisome Proliferator-Activated Receptors

(2010) Paola Mascia et al.   BIOLOGICAL PSYCHIATRY

Cannabinoid-Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders

(2010) Javier Fernández-Ruiz et al.   CNS Neuroscience & Therapeutics

Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain

(2010) Harald S. Hansen   EXPERIMENTAL NEUROLOGY

Biomarkers of Endocannabinoid System Activation in Severe Obesity

(2010) Jack C. Sipe et al.   PLoS One

Enhanced Anandamide Plasma Levels in Patients with Complex Regional Pain Syndrome following Traumatic Injury: A Preliminary Report

(2009) I. Kaufmann et al.   EUROPEAN SURGICAL RESEARCH

Plasma endocannabinoid levels in multiple sclerosis

(2009) L. Jean-Gilles et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study

(2009) Jeremy Koppel et al.   Lipids in Health and Disease

An endocannabinoid signal associated with desire for alcohol is suppressed in recently abstinent alcoholics

(2009) Regina A. Mangieri et al.   PSYCHOPHARMACOLOGY

Effects of the endogenous PPAR-α agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice

(2009) Ainhoa Plaza-Zabala et al.   SYNAPSE

Psychiatric comorbidity in young cocaine users: induced versus independent disorders

(2008) M. Jesús Herrero et al.   ADDICTION

The role of CB1 receptors in psychostimulant addiction

(2008) Joost Wiskerke et al.   ADDICTION BIOLOGY

Illicit Stimulant Use in a United States Heart Failure Population Presenting to the Emergency Department (from the Acute Decompensated Heart Failure National Registry Emergency Module)

(2008) Deborah B. Diercks et al.   AMERICAN JOURNAL OF CARDIOLOGY

Neuroplasticity in the mesolimbic dopamine system and cocaine addiction

(2008) M J Thomas et al.   BRITISH JOURNAL OF PHARMACOLOGY

Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy

(2008) Stéphane Potvin et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Serum Endocannabinoid Content is Altered in Females with Depressive Disorders: A Preliminary Report

(2008) M. Hill et al.   PHARMACOPSYCHIATRY

Anandamide and neutrophil function in patients with fibromyalgia

(2008) Ines Kaufmann et al.   PSYCHONEUROENDOCRINOLOGY